한강화학

비상장계속사업자

HANKANG CHEMICALS CO.,LTD

김무수

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

한강화학

Business Reg. No. 1208135438 · CEO 김무수

I.Investment Overview

Target한강화학 (1208135438)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명한강화학
영문명HANKANG CHEMICALS CO.,LTD
대표자김무수
사업자등록번호1208135438
법인등록번호1101110877419
설립일1992.07.14

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW302.62021400.82022391.32023414.420245132025
영업이익100M KRW33.2202144.4202216202334.520241012025
순이익100M KRW17.1202131.920229.4202317.5202488.32025
Item20252024202320222021
자산총계385억원286.4억원273.9억원282.6억원239.9억원
부채총계129.5억원119.2억원112.3억원127.9억원113.3억원
자본총계255.5억원167.2억원161.6억원154.7억원126.5억원
매출액513억원414.4억원391.3억원400.8억원302.6억원
영업이익101억원34.5억원16억원44.4억원33.2억원
순이익88.3억원17.5억원9.4억원31.9억원17.1억원

VI.Financial Ratios

FY2025 basis

19.69%

영업이익률

17.21%

순이익률

22.94%

ROA

34.56%

ROE

50.68%

부채비율

66.37%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

한강화학 투심보고서 | Alpha Lenz